ArticleCommunications medicine2023

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.

Scott A Tomlins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.